Inventors with similar research interests:
Location History:
- Boston, MA (US) (1995 - 1998)
- Berkley, CA (US) (1996 - 1999)
- Hayward, CA (US) (1999)
- Berkeley, CA (US) (1994 - 2000)
- Oakland, CA (US) (1998 - 2008)
- Alamo, CA (US) (2002 - 2019)
Company Filing History:
67 out of 130 
3 out of 3 
1 out of 1 
Years Active: 1994-2019
Areas of Expertise:
Title: Reid M Rubsamen: Pioneering Innovation Through Patents
Introduction:
Reid M Rubsamen, a skilled inventor and scientist based in Berkeley, CA, has made significant contributions to the field of biotechnology and pharmaceuticals. With an impressive portfolio of 74 patents, Rubsamen's groundbreaking work in peptide particle formulation has positioned him as a leading innovator in the industry. This article explores Rubsamen's latest patents, career highlights, notable collaborations, and his continued dedication to advancing scientific knowledge.
Latest Patents:
Rubsamen's latest patents showcase his expertise in peptide particle formulation. The composition he has developed involves the use of biocompatible polymers, such as PLGA, combined with specific peptides. These peptides correspond to sequences presented on the surface of cells infected with viruses. By creating particles of varying groups, each containing peptides of identical amino acid sequences, Rubsamen's invention effectively delivers controlled doses of antigenic material to the immune system cells. The sizing of these particles ensures that only the contents of a single particle are presented to a single immune system cell. This patented formulation holds immense potential in the development of targeted therapeutics and vaccines.
Career Highlights:
Throughout his career, Rubsamen has been affiliated with esteemed companies in the biotech sector. He has made notable contributions at Aradigm Corporation, a renowned innovator in inhalation drug delivery solutions. Rubsamen's expertise in drug delivery systems undoubtedly played a crucial role in pushing the boundaries of medical treatment. Additionally, his tenure at Flow Pharma, Inc. further solidifies his commitment to advancing healthcare through cutting-edge research and development efforts.
Collaborations:
Rubsamen's work also highlights his fruitful collaborations with fellow experts in the field. One notable collaboration has been with Lester John Lloyd, a revered scientist who shares Rubsamen's passion for drug development. Together, they have undoubtedly exchanged ideas and propelled advancements in their respective fields. Furthermore, Rubsamen's collaboration with Igor Gonda, another prominent figure in biotechnology, has likely paved the way for groundbreaking research initiatives.
Conclusion:
Reid M Rubsamen's career has been marked by his unwavering dedication to innovation and his exceptional ability to translate scientific concepts into tangible inventions. With an impressive array of patents, his contributions to the field of peptide particle formulation have the potential to revolutionize drug delivery and vaccination strategies. Rubsamen's collaborations with prominent figures serve as a testament to his collaborative spirit and commitment to advancing the scientific community. As he continues to push boundaries and explore novel solutions, we anticipate further breakthroughs from this visionary inventor.